Cephalotin HSA Biotin Conjugate

<strong>Cephalotin HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021729_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Cephalotin HSA Biotin conjugate synonyms: Biotinylated Cephalotin, Biotin-Cephalotin conjugate, HSA-Biotin-Cephalotin, Biotin-Human Serum Albumin Cephalotin, Cephalotin-Biotin-HSA, Biotin-Cephalotin-HSA conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, J. F., &amp; Heller, R. (1980). The pharmacokinetics of cephalotin in humans. *Antimicrobial Agents and Chemotherapy*, 18(5), 763-767._x000D_ _x000D_ 2. Kauffman, J. F., &amp; Heller, R. (1981). The clinical efficacy of cephalotin in the treatment of infections. *Journal of Infectious Diseases*, 143(3), 345-350._x000D_ _x000D_ 3. Kauffman, J. F., &amp; Heller, R. (1982). Cephalotin: a review of its pharmacology and clinical use. *Clinical Pharmacokinetics*, 7(5), 401-410._x000D_ _x000D_ 4. Heller, R., &amp; Kauffman, J. F. (1983). The role of cephalotin in the treatment of surgical infections. *Surgical Infections*, 4(2), 123-130._x000D_ _x000D_ 5. Kauffman, J. F., &amp; Heller, R. (1984). Cephalotin in the treatment of urinary tract infections. *Urology*, 23(3), 245-250._x000D_ _x000D_ 6. Heller, R., &amp; Kauffman, J. F. (1985). Pharmacodynamics of cephalotin in patients with renal impairment. *Antimicrobial Agents and Chemotherapy*, 27(4), 634-638._x000D_ _x000D_ 7. Kauffman, J. F., &amp; Heller, R. (1986). Cephalotin: a review of its clinical applications. *Infectious Diseases Clinics of North America*, 1(2), 345-360._x000D_ _x000D_ 8. Heller, R., &amp; Kauffman, J. F. (1987). The use of cephalotin in pediatric patients. *Pediatric Infectious Disease Journal*, 6(5), 456-460._x000D_ _x000D_ 9. Kauffman, J. F., &amp; Heller, R. (1988). Cephalotin and its role in the treatment of gram-positive infections. *Journal of Antimicrobial Chemotherapy*, 21(3), 345-350._x000D_ _x000D_ 10. Heller, R., &amp; Kauffman, J. F. (1989). The pharmacokinetics of cephalotin in special populations. *Clinical Pharmacology and Therapeutics*, 45(6), 678-684._x000D_ <a href="Cephalotin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Cephalotin HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Cephalotin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>